Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.

Facioscapulohumeral muscular dystrophy (FSHD) is an untreatable disease, characterized by asymmetric progressive weakness of skeletal muscle with fatty infiltration. Although the main genetic defect has been uncovered, the downstream mechanisms causing FSHD are not understood. The objective of this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Barbara H Janssen, Nicoline B M Voet, Christine I Nabuurs, Hermien E Kan, Jacky W J de Rooy, Alexander C Geurts, George W Padberg, Baziel G M van Engelen, Arend Heerschap
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9c41ae2c80b64b588942b7eadbec58ea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9c41ae2c80b64b588942b7eadbec58ea
record_format dspace
spelling oai:doaj.org-article:9c41ae2c80b64b588942b7eadbec58ea2021-11-18T08:37:49ZDistinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.1932-620310.1371/journal.pone.0085416https://doaj.org/article/9c41ae2c80b64b588942b7eadbec58ea2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24454861/?tool=EBIhttps://doaj.org/toc/1932-6203Facioscapulohumeral muscular dystrophy (FSHD) is an untreatable disease, characterized by asymmetric progressive weakness of skeletal muscle with fatty infiltration. Although the main genetic defect has been uncovered, the downstream mechanisms causing FSHD are not understood. The objective of this study was to determine natural disease state and progression in muscles of FSHD patients and to establish diagnostic biomarkers by quantitative MRI of fat infiltration and phosphorylated metabolites. MRI was performed at 3T with dedicated coils on legs of 41 patients (28 men/13 women, age 34-76 years), of which eleven were re-examined after four months of usual care. Muscular fat fraction was determined with multi spin-echo and T1 weighted MRI, edema by TIRM and phosphorylated metabolites by 3D (31)P MR spectroscopic imaging. Fat fractions were compared to clinical severity, muscle force, age, edema and phosphocreatine (PCr)/ATP. Longitudinal intramuscular fat fraction variation was analyzed by linear regression. Increased intramuscular fat correlated with age (p<0.05), FSHD severity score (p<0.0001), inversely with muscle strength (p<0.0001), and also occurred sub-clinically. Muscles were nearly dichotomously divided in those with high and with low fat fraction, with only 13% having an intermediate fat fraction. The intramuscular fat fraction along the muscle's length, increased from proximal to distal. This fat gradient was the steepest for intermediate fat infiltrated muscles (0.07±0.01/cm, p<0.001). Leg muscles in this intermediate phase showed a decreased PCr/ATP (p<0.05) and the fastest increase in fatty infiltration over time (0.18±0.15/year, p<0.001), which correlated with initial edema (p<0.01), if present. Thus, in the MR assessment of fat infiltration as biomarker for diseased muscles, the intramuscular fat distribution needs to be taken into account. Our results indicate that healthy individual leg muscles become diseased by entering a progressive phase with distal fat infiltration and altered energy metabolite levels. Fat replacement then relatively rapidly spreads over the whole muscle.Barbara H JanssenNicoline B M VoetChristine I NabuursHermien E KanJacky W J de RooyAlexander C GeurtsGeorge W PadbergBaziel G M van EngelenArend HeerschapPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 1, p e85416 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Barbara H Janssen
Nicoline B M Voet
Christine I Nabuurs
Hermien E Kan
Jacky W J de Rooy
Alexander C Geurts
George W Padberg
Baziel G M van Engelen
Arend Heerschap
Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
description Facioscapulohumeral muscular dystrophy (FSHD) is an untreatable disease, characterized by asymmetric progressive weakness of skeletal muscle with fatty infiltration. Although the main genetic defect has been uncovered, the downstream mechanisms causing FSHD are not understood. The objective of this study was to determine natural disease state and progression in muscles of FSHD patients and to establish diagnostic biomarkers by quantitative MRI of fat infiltration and phosphorylated metabolites. MRI was performed at 3T with dedicated coils on legs of 41 patients (28 men/13 women, age 34-76 years), of which eleven were re-examined after four months of usual care. Muscular fat fraction was determined with multi spin-echo and T1 weighted MRI, edema by TIRM and phosphorylated metabolites by 3D (31)P MR spectroscopic imaging. Fat fractions were compared to clinical severity, muscle force, age, edema and phosphocreatine (PCr)/ATP. Longitudinal intramuscular fat fraction variation was analyzed by linear regression. Increased intramuscular fat correlated with age (p<0.05), FSHD severity score (p<0.0001), inversely with muscle strength (p<0.0001), and also occurred sub-clinically. Muscles were nearly dichotomously divided in those with high and with low fat fraction, with only 13% having an intermediate fat fraction. The intramuscular fat fraction along the muscle's length, increased from proximal to distal. This fat gradient was the steepest for intermediate fat infiltrated muscles (0.07±0.01/cm, p<0.001). Leg muscles in this intermediate phase showed a decreased PCr/ATP (p<0.05) and the fastest increase in fatty infiltration over time (0.18±0.15/year, p<0.001), which correlated with initial edema (p<0.01), if present. Thus, in the MR assessment of fat infiltration as biomarker for diseased muscles, the intramuscular fat distribution needs to be taken into account. Our results indicate that healthy individual leg muscles become diseased by entering a progressive phase with distal fat infiltration and altered energy metabolite levels. Fat replacement then relatively rapidly spreads over the whole muscle.
format article
author Barbara H Janssen
Nicoline B M Voet
Christine I Nabuurs
Hermien E Kan
Jacky W J de Rooy
Alexander C Geurts
George W Padberg
Baziel G M van Engelen
Arend Heerschap
author_facet Barbara H Janssen
Nicoline B M Voet
Christine I Nabuurs
Hermien E Kan
Jacky W J de Rooy
Alexander C Geurts
George W Padberg
Baziel G M van Engelen
Arend Heerschap
author_sort Barbara H Janssen
title Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
title_short Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
title_full Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
title_fullStr Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
title_full_unstemmed Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
title_sort distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by mr detected fat infiltration.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/9c41ae2c80b64b588942b7eadbec58ea
work_keys_str_mv AT barbarahjanssen distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
AT nicolinebmvoet distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
AT christineinabuurs distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
AT hermienekan distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
AT jackywjderooy distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
AT alexandercgeurts distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
AT georgewpadberg distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
AT bazielgmvanengelen distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
AT arendheerschap distinctdiseasephasesinmusclesoffacioscapulohumeraldystrophypatientsidentifiedbymrdetectedfatinfiltration
_version_ 1718421517004439552